"Semaglutide's Heart-Healthy Benefits Boost Novo Nordisk and Eli Lilly's Outlook"
Data released by Novo Nordisk confirms that their weight loss drug Wegovy can reduce the risk of strokes and heart attacks, but concerns over the cost of the medicine remain.